José-Luis Pérez-Castrillón

8PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersClinical chemistry (incl. diagnostics)Cancer therapy (excl. chemotherapy and radiation therapy)Structural properties of condensed matterHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 28, 2025
A Machine Learning Approach to Understanding the Genetic Role in COVID-19 Prognosis: The Influence of Gene Polymorphisms Related to Inflammation, Vitamin D, and ACE2.

Sofía Jaurrieta-Largo, José Pablo Miramontes-González, Luis Corral-Gudino

|May 14, 2025
Analysis of the Efficacy and Safety of Weekly Calcifediol 100 µg in Vitamin D Deficient Patients.

Jose Luis Pérez Castrillón, Esteban Jódar-Gimeno, Koldobika Molina

|Feb 26, 2025
A Randomized Phase II/III Trial Evaluating the Efficacy and Safety of 100 and 125 µg of Calcifediol Weekly Treatment of Severe Vitamin D Deficiency.

Jose Luis Pérez-Castrillón, Esteban Jódar-Gimeno, Ján Nociar

|Nov 27, 2024
Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial.

Esteban Jódar-Gimeno, Jose Luis Pérez-Castrillón, Ján Nociar

|Nov 06, 2024
Novel MYORG Variant Linked to Primary Familial Brain Calcification.

Andreea Catalina Cristea, José Luís Pérez-Castrillón, Ricardo Usategui-Martin

|Feb 24, 2024
High Frequencies of Genetic Variants in Patients with Atypical Femoral Fractures.

Álvaro Del Real, Raquel Cruz, Carolina Sañudo

Pageof 2

Frequent Collaborators

3 joint publications

Esteban Jódar-Gimeno

3 joint publications

Ricardo Usategui-Martin

2 joint publications

Umberto Tarantino

2 joint publications

Michal Lojka